Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA Advisory Panel Backs Claret’s Sentinel TAVR Filter

Executive Summary

The panelists said the agency should approve the filter, which is used to protect the brain during transcatheter aortic heart-valve replacement surgery, despite ongoing questions about its effectiveness.

Advertisement

Related Content

Market Intel: Increasingly Less-Invasive Diagnostic Techs To Disrupt Interventional Cardio Market
FDA Go-Ahead For Sentinel TAVR Filter Could Drive Procedure Volumes, Firm Says
First TAVR Filter To Reach FDA Panel Will Get Questions On Missed Endpoint

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT104505

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel